{
  "paper": {
    "doi": null,
    "pmcid": "PMC12757875",
    "title": "The DDR-immune fitness score: a biomarker for guiding parp and immunotherapy synergy in extensive-stage small cell lung cancer",
    "authors": [],
    "journal": null,
    "year": null,
    "study_type": "biomarker development",
    "eco_type": null
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "777544707e2808fd01d9cb8fbe5dc1d74b29532b",
      "git_commit_short": "7775447",
      "git_branch": "main",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:5bdf447f3cfe242d"
    },
    "execution": {
      "timestamp": "2026-02-27T16:08:03.257995Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 58.86
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "extensive-stage small cell lung cancer",
      "class": "Disease",
      "name": "extensive-stage small cell lung cancer",
      "synonyms": [
        "ES-SCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "small cell lung cancer",
      "class": "Disease",
      "name": "small cell lung cancer",
      "synonyms": [
        "SCLC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "DDR-Immune Fitness score",
      "class": "Biomarker",
      "name": "DDR-Immune Fitness score",
      "synonyms": [
        "DDR-IF score"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "homologous recombination deficiency",
      "class": "Biomarker",
      "name": "homologous recombination deficiency",
      "synonyms": [
        "HRD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "tumor mutational burden",
      "class": "Biomarker",
      "name": "tumor mutational burden",
      "synonyms": [
        "TMB"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "STING pathway",
      "class": "Pathway",
      "name": "STING pathway",
      "synonyms": [
        "cGAS-STING pathway"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PARP inhibitor",
      "class": "Drug",
      "name": "PARP inhibitor",
      "synonyms": [
        "PARPi"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "immune checkpoint blocker",
      "class": "Drug",
      "name": "immune checkpoint blocker",
      "synonyms": [
        "ICB"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PD-L1",
      "class": "Protein",
      "name": "PD-L1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "ATM",
      "class": "Gene",
      "name": "ATM",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "BRCA1",
      "class": "Gene",
      "name": "BRCA1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "BRCA2",
      "class": "Gene",
      "name": "BRCA2",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "PARP1",
      "class": "Protein",
      "name": "PARP1",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "RAD51",
      "class": "Protein",
      "name": "RAD51",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "SLFN11",
      "class": "Protein",
      "name": "SLFN11",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "cGAS",
      "class": "Protein",
      "name": "cGAS",
      "synonyms": [
        "cyclic GMP-AMP synthase"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "STING",
      "class": "Protein",
      "name": "STING",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "CD8+ T cells",
      "class": "AnatomicalStructure",
      "name": "CD8+ T cells",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "olaparib",
      "class": "Drug",
      "name": "olaparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "durvalumab",
      "class": "Drug",
      "name": "durvalumab",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "talazoparib",
      "class": "Drug",
      "name": "talazoparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "niraparib",
      "class": "Drug",
      "name": "niraparib",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "lurbinectedin",
      "class": "Drug",
      "name": "lurbinectedin",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "CYT-0851",
      "class": "Drug",
      "name": "CYT-0851",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "AZD6738",
      "class": "Drug",
      "name": "AZD6738",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "objective response rate",
      "class": "Biomarker",
      "name": "objective response rate",
      "synonyms": [
        "ORR"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "progression-free survival",
      "class": "Biomarker",
      "name": "progression-free survival",
      "synonyms": [
        "PFS"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "DNA damage repair",
      "class": "BiologicalProcess",
      "name": "DNA damage repair",
      "synonyms": [
        "DDR"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "genomic instability",
      "class": "BiologicalProcess",
      "name": "genomic instability",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "immune evasion",
      "class": "BiologicalProcess",
      "name": "immune evasion",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "synthetic lethality",
      "class": "BiologicalProcess",
      "name": "synthetic lethality",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "tumor microenvironment",
      "class": "AnatomicalStructure",
      "name": "tumor microenvironment",
      "synonyms": [
        "TME"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "single-cell RNA sequencing",
      "class": "Procedure",
      "name": "single-cell RNA sequencing",
      "synonyms": [
        "scRNA-seq"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "elastic-net regression",
      "class": "StatisticalMethod",
      "name": "elastic-net regression",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "area under the receiver operating characteristic curve",
      "class": "StatisticalMethod",
      "name": "area under the receiver operating characteristic curve",
      "synonyms": [
        "AUROC"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "MSK-IMPACT study",
      "class": "ClinicalTrial",
      "name": "MSK-IMPACT study",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "NCT02484404",
      "class": "ClinicalTrial",
      "name": "NCT02484404",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "NCT04564027",
      "class": "ClinicalTrial",
      "name": "NCT04564027",
      "synonyms": [],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_1:background:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "background_1",
      "text": "Despite the integration of PD-L1 inhibitors with chemotherapy, extensive-stage small-cell lung cancer (ES-SCLC) continues to portend a dismal prognosis, with a 5-year survival rate below 10%",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_1",
      "text": "DDR-IF-high tumors were characterized by a distinct biological profile, including (i) transcriptional exhaustion of the cGAS-STING innate immune pathway (p < 0.001), (ii) significantly reduced CD8+ T cell infiltration (2.3-fold fewer, p = 0.004), and (iii) a superior pooled objective response rate to PARP-ICB combinations (42% vs 18%; risk ratio 2.3, 95% CI 1.3-4.2; p = 0.003)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:methods:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "methods_1",
      "text": "The DDR-IF score was defined using standardized coefficients: DDR-IF = 0.4 \u00d7 (HRD score) + 0.35 \u00d7 log10(TMB + 1) + 0.25 \u00d7 (STING activation score)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:section4:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "section4_1",
      "text": "A meta-analysis of six trials (2020\u20132024) confirmed that DDR-IF-high tumors (e.g., ATM/BRCA1/2-altered) show a 2.3-fold higher ORR to PARP-ICB versus DDR-IF-low (42% vs. 18%, p=0.003)",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": null,
      "source": "extracted"
    },
    {
      "id": "paper_1:section6:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "section6_1",
      "text": "In the SCLC-specific phase Ib trial NCT04564027, the RAD51 inhibitor CYT-0851 achieved a 38% disease control rate, with matched biopsies revealing a STING-dependent 6.8-fold increase in CXCL10 (p=0.02)",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "biomarker development",
      "eco_type": null,
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "extensive-stage small cell lung cancer",
      "predicate": "SUBTYPE_OF",
      "object": "small cell lung cancer",
      "evidence_ids": [
        "paper_1:background:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "DDR-Immune Fitness score",
      "predicate": "INDICATES",
      "object": "extensive-stage small cell lung cancer",
      "evidence_ids": [
        "paper_1:results:1:llm",
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "biomarker_type": "composite",
        "components": [
          "HRD",
          "TMB",
          "STING"
        ]
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "PARP inhibitor",
      "predicate": "TREATS",
      "object": "extensive-stage small cell lung cancer",
      "evidence_ids": [
        "paper_1:results:1:llm",
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "combination_therapy": true,
        "partner": "immune checkpoint blocker"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "immune checkpoint blocker",
      "predicate": "TREATS",
      "object": "extensive-stage small cell lung cancer",
      "evidence_ids": [
        "paper_1:results:1:llm",
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "combination_therapy": true,
        "partner": "PARP inhibitor"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "DDR-Immune Fitness score",
      "predicate": "ASSOCIATED_WITH",
      "object": "objective response rate",
      "evidence_ids": [
        "paper_1:results:1:llm",
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "high_score_ORR": "42%",
        "low_score_ORR": "18%",
        "risk_ratio": "2.3"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "homologous recombination deficiency",
      "predicate": "ASSOCIATED_WITH",
      "object": "genomic instability",
      "evidence_ids": [
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "component_weight": "0.4"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "tumor mutational burden",
      "predicate": "ASSOCIATED_WITH",
      "object": "genomic instability",
      "evidence_ids": [
        "paper_1:methods:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "component_weight": "0.35"
      },
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "STING pathway",
      "predicate": "ASSOCIATED_WITH",
      "object": "immune evasion",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "pathway_state": "exhausted",
        "component_weight": "0.25"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "ATM",
      "predicate": "ASSOCIATED_WITH",
      "object": "DNA damage repair",
      "evidence_ids": [
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mutation_frequency": "11.2%"
      },
      "section": "section4",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRCA1",
      "predicate": "ASSOCIATED_WITH",
      "object": "DNA damage repair",
      "evidence_ids": [
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "section4",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "BRCA2",
      "predicate": "ASSOCIATED_WITH",
      "object": "DNA damage repair",
      "evidence_ids": [
        "paper_1:section4:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "mutation_frequency": "6.7%"
      },
      "section": "section4",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "CYT-0851",
      "predicate": "TREATS",
      "object": "small cell lung cancer",
      "evidence_ids": [
        "paper_1:section6:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "drug_type": "RAD51 inhibitor",
        "disease_control_rate": "38%"
      },
      "section": "section6",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "olaparib",
      "predicate": "SAME_AS",
      "object": "PARP inhibitor",
      "evidence_ids": [],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "general",
      "asserted_by": "llm",
      "resolution": null,
      "note": "olaparib is a specific PARP inhibitor"
    },
    {
      "subject": "durvalumab",
      "predicate": "SAME_AS",
      "object": "immune checkpoint blocker",
      "evidence_ids": [],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {},
      "section": "general",
      "asserted_by": "llm",
      "resolution": null,
      "note": "durvalumab is a specific PD-L1 inhibitor"
    },
    {
      "subject": "CD8+ T cells",
      "predicate": "ASSOCIATED_WITH",
      "object": "tumor microenvironment",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "infiltration_reduction": "2.3-fold"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "synthetic lethality",
      "predicate": "ASSOCIATED_WITH",
      "object": "PARP inhibitor",
      "evidence_ids": [
        "paper_1:section6:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "mechanism": "DDR deficiency"
      },
      "section": "section6",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    }
  ],
  "notes": [
    "The DDR-IF score is described as exploratory and requires prospective validation",
    "The study integrates data from 82 SCLC tumors and six phase II trials",
    "Ethnic variability may influence the score's predictive power",
    "Technical standardization of STING quantification is needed for clinical implementation"
  ]
}